Roivant Sciences (ROIV) Exchange Rate Effect (2023 - 2025)
Roivant Sciences (ROIV) reported Exchange Rate Effect of $2.5 million for Q4 2025, up 98.3% on a YoY basis from $1.2 million in Q4 2024, and up 103.23% quarter-over-quarter from $1.2 million in Q3 2025.
Roivant Sciences (ROIV) Exchange Rate Effect (2023 - 2025) Analysis & Trends
Roivant Sciences has reported Exchange Rate Effect for 3 years, with the latest figure at $2.5 million in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect rose 98.3% year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2025 stood at $5.7 million (up 13.93% YoY), and the FY2026 full-year result was $3.8 million, up 404.28% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at $2.5 million, up from $1.2 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $5.0 million in Q3 2024, with the low at -$2.7 million in Q2 2024.
- Historically, Exchange Rate Effect has averaged $879000.0 across 3 years, with a median of $1.2 million in 2025.
- The largest YoY upside for Exchange Rate Effect was 446.84% in 2024 against a maximum downside of 2241.88% in 2024.
- Roivant Sciences' Exchange Rate Effect stood at $1.5 million in 2023, then decreased by 15.98% to $1.2 million in 2024, then soared by 98.3% to $2.5 million in 2025.
- The last three Exchange Rate Effect figures came in at $2.5 million (Q4 2025), $1.2 million (Q3 2025), and $815000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.45 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 815,000.00 |
| Jun 30, 2025 | 815,000.00 |
| Dec 31, 2024 | 1.24 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 5.04 Mn |
| Sep 30, 2024 | 5.04 Mn |
| Jun 30, 2024 | -2.74 Mn |
| Jun 30, 2024 | -2.74 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | -1.45 Mn |
| Sep 30, 2023 | -1.45 Mn |
| Jun 30, 2023 | -117,000.00 |
| Jun 30, 2023 | -117,000.00 |